Optimizing Dendritic Cell-Based Immunotherapy: Tackling the Complexity of Different Arms of the Immune System

Earlier investigations have revealed a surprising complexity and variety in the range of interaction between cells of the innate and adaptive immune system. Our understanding of the specialized roles of dendritic cell (DC) subsets in innate and adaptive immune responses has been significantly advanc...

Full description

Saved in:
Bibliographic Details
Main Authors: Ilse Van Brussel, Zwi N. Berneman, Nathalie Cools
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2012/690643
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849387160978849792
author Ilse Van Brussel
Zwi N. Berneman
Nathalie Cools
author_facet Ilse Van Brussel
Zwi N. Berneman
Nathalie Cools
author_sort Ilse Van Brussel
collection DOAJ
description Earlier investigations have revealed a surprising complexity and variety in the range of interaction between cells of the innate and adaptive immune system. Our understanding of the specialized roles of dendritic cell (DC) subsets in innate and adaptive immune responses has been significantly advanced over the years. Because of their immunoregulatory capacities and because very small numbers of activated DC are highly efficient at generating immune responses against antigens, DCs have been vigorously used in clinical trials in order to elicit or amplify immune responses against cancer and chronic infectious diseases. A better insight in DC immunobiology and function has stimulated many new ideas regarding the potential ways forward to improve DC therapy in a more fundamental way. Here, we discuss the continuous search for optimal in vitro conditions in order to generate clinical-grade DC with a potent immunogenic potential. For this, we explore the molecular and cellular mechanisms underlying adequate immune responses and focus on most favourable DC culture regimens and activation stimuli in humans. We envisage that by combining each of the features outlined in the current paper into a unified strategy, DC-based vaccines may advance to a higher level of effectiveness.
format Article
id doaj-art-330bcf93698a4732aed027dd48ff5e81
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-330bcf93698a4732aed027dd48ff5e812025-08-20T03:55:17ZengWileyMediators of Inflammation0962-93511466-18612012-01-01201210.1155/2012/690643690643Optimizing Dendritic Cell-Based Immunotherapy: Tackling the Complexity of Different Arms of the Immune SystemIlse Van Brussel0Zwi N. Berneman1Nathalie Cools2Laboratory of Pharmacology, Department of Translational Pathophysiological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, 2610 Antwerp, BelgiumLaboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, 2610 Antwerp, BelgiumLaboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, 2610 Antwerp, BelgiumEarlier investigations have revealed a surprising complexity and variety in the range of interaction between cells of the innate and adaptive immune system. Our understanding of the specialized roles of dendritic cell (DC) subsets in innate and adaptive immune responses has been significantly advanced over the years. Because of their immunoregulatory capacities and because very small numbers of activated DC are highly efficient at generating immune responses against antigens, DCs have been vigorously used in clinical trials in order to elicit or amplify immune responses against cancer and chronic infectious diseases. A better insight in DC immunobiology and function has stimulated many new ideas regarding the potential ways forward to improve DC therapy in a more fundamental way. Here, we discuss the continuous search for optimal in vitro conditions in order to generate clinical-grade DC with a potent immunogenic potential. For this, we explore the molecular and cellular mechanisms underlying adequate immune responses and focus on most favourable DC culture regimens and activation stimuli in humans. We envisage that by combining each of the features outlined in the current paper into a unified strategy, DC-based vaccines may advance to a higher level of effectiveness.http://dx.doi.org/10.1155/2012/690643
spellingShingle Ilse Van Brussel
Zwi N. Berneman
Nathalie Cools
Optimizing Dendritic Cell-Based Immunotherapy: Tackling the Complexity of Different Arms of the Immune System
Mediators of Inflammation
title Optimizing Dendritic Cell-Based Immunotherapy: Tackling the Complexity of Different Arms of the Immune System
title_full Optimizing Dendritic Cell-Based Immunotherapy: Tackling the Complexity of Different Arms of the Immune System
title_fullStr Optimizing Dendritic Cell-Based Immunotherapy: Tackling the Complexity of Different Arms of the Immune System
title_full_unstemmed Optimizing Dendritic Cell-Based Immunotherapy: Tackling the Complexity of Different Arms of the Immune System
title_short Optimizing Dendritic Cell-Based Immunotherapy: Tackling the Complexity of Different Arms of the Immune System
title_sort optimizing dendritic cell based immunotherapy tackling the complexity of different arms of the immune system
url http://dx.doi.org/10.1155/2012/690643
work_keys_str_mv AT ilsevanbrussel optimizingdendriticcellbasedimmunotherapytacklingthecomplexityofdifferentarmsoftheimmunesystem
AT zwinberneman optimizingdendriticcellbasedimmunotherapytacklingthecomplexityofdifferentarmsoftheimmunesystem
AT nathaliecools optimizingdendriticcellbasedimmunotherapytacklingthecomplexityofdifferentarmsoftheimmunesystem